JPS5753410A - A type hepatitis virus high value production - Google Patents

A type hepatitis virus high value production

Info

Publication number
JPS5753410A
JPS5753410A JP56114522A JP11452281A JPS5753410A JP S5753410 A JPS5753410 A JP S5753410A JP 56114522 A JP56114522 A JP 56114522A JP 11452281 A JP11452281 A JP 11452281A JP S5753410 A JPS5753410 A JP S5753410A
Authority
JP
Japan
Prior art keywords
high value
hepatitis virus
type hepatitis
value production
virus high
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56114522A
Other languages
English (en)
Japanese (ja)
Inventor
Zetsuto Maakasu Henrii
Jiee Makuaree Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5753410A publication Critical patent/JPS5753410A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP56114522A 1980-07-23 1981-07-23 A type hepatitis virus high value production Pending JPS5753410A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/171,621 US4301249A (en) 1980-07-23 1980-07-23 High titer production of hepatitis A virus

Publications (1)

Publication Number Publication Date
JPS5753410A true JPS5753410A (en) 1982-03-30

Family

ID=22624494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56114522A Pending JPS5753410A (en) 1980-07-23 1981-07-23 A type hepatitis virus high value production

Country Status (11)

Country Link
US (1) US4301249A (cg-RX-API-DMAC7.html)
EP (1) EP0044793B1 (cg-RX-API-DMAC7.html)
JP (1) JPS5753410A (cg-RX-API-DMAC7.html)
AT (1) ATE20250T1 (cg-RX-API-DMAC7.html)
CA (1) CA1187413A (cg-RX-API-DMAC7.html)
DE (1) DE3174765D1 (cg-RX-API-DMAC7.html)
DK (1) DK326781A (cg-RX-API-DMAC7.html)
ES (1) ES504199A0 (cg-RX-API-DMAC7.html)
GR (1) GR74594B (cg-RX-API-DMAC7.html)
IE (1) IE51454B1 (cg-RX-API-DMAC7.html)
PT (1) PT73371B (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010004802A (ja) * 2008-06-26 2010-01-14 Toyobo Co Ltd 感染性c型肝炎ウイルス粒子の製造方法、およびその利用
JP5327793B2 (ja) * 2006-09-26 2013-10-30 国立大学法人京都大学 肝炎ウイルスの増殖方法、及びその利用

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783407A (en) * 1985-09-30 1988-11-08 Merck & Co., Inc. Growth of hepatitus A virus in vero cells
DE3633550A1 (de) * 1986-10-02 1988-04-14 Behringwerke Ag Vaccine gegen hepatitis a
US5268292A (en) * 1988-06-27 1993-12-07 Robertson Betty H Reproducible generation of high yields of hepatitis A virus by cell culture
AU650711B2 (en) * 1990-12-13 1994-06-30 Cellco, Inc. Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
US5506129A (en) * 1991-05-24 1996-04-09 Evans Medical Limited Virus production
DZ1706A1 (fr) * 1992-08-07 2002-02-17 Merck & Co Inc Vaccin contre le virus de l'hepatite a.
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
EP1497444B1 (en) * 2002-03-27 2015-11-04 Immunex Corporation Methods for increasing polypeptide production
MX2009011899A (es) * 2007-05-04 2010-03-30 Baxter Int Perfil de temperatura de dos pasos para la propagacion de virus.
WO2012122625A1 (en) 2011-03-14 2012-09-20 National Research Council Of Canada Method of viral production in cells

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
JPS52125688A (en) * 1976-04-12 1977-10-21 Monsanto Co Method and reaction container for coltivating cell
JPS5548389A (en) * 1978-08-17 1980-04-07 Merck & Co Inc In vitro cell culturing of hepatitis a virus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615024A (en) * 1968-08-26 1971-10-26 Amicon Corp High flow membrane
FR2398504A1 (fr) 1977-07-29 1979-02-23 Tours Inst Virologie Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4301250A (en) * 1979-11-02 1981-11-17 Merck & Co., Inc. Method of producing hepatitis B surface antigen

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
US3883393A (en) * 1972-05-18 1975-05-13 Us Health Education & Welfare Cell culture on semi-permeable tubular membranes
US3997396A (en) * 1973-07-02 1976-12-14 Monsanto Company Method for the in vitro propagation and maintenance of cells
JPS52125688A (en) * 1976-04-12 1977-10-21 Monsanto Co Method and reaction container for coltivating cell
JPS5548389A (en) * 1978-08-17 1980-04-07 Merck & Co Inc In vitro cell culturing of hepatitis a virus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5327793B2 (ja) * 2006-09-26 2013-10-30 国立大学法人京都大学 肝炎ウイルスの増殖方法、及びその利用
JP2010004802A (ja) * 2008-06-26 2010-01-14 Toyobo Co Ltd 感染性c型肝炎ウイルス粒子の製造方法、およびその利用

Also Published As

Publication number Publication date
CA1187413A (en) 1985-05-21
DK326781A (da) 1982-01-24
GR74594B (cg-RX-API-DMAC7.html) 1984-06-29
EP0044793A2 (en) 1982-01-27
IE51454B1 (en) 1986-12-24
PT73371A (en) 1981-08-01
ES8205016A1 (es) 1982-05-16
PT73371B (en) 1983-06-15
US4301249A (en) 1981-11-17
IE811655L (en) 1982-01-23
DE3174765D1 (en) 1986-07-10
ATE20250T1 (de) 1986-06-15
EP0044793B1 (en) 1986-06-04
ES504199A0 (es) 1982-05-16
EP0044793A3 (en) 1983-01-05

Similar Documents

Publication Publication Date Title
JPS5753410A (en) A type hepatitis virus high value production
IE882407L (en) Purifying hepatitis a virus
NO861839L (no) Dyrkningssubstrat.
DE69022595D1 (de) Herstellung von kohlefaser-halbfabrikaten.
DE3260046D1 (en) Method of producing hepatitis b surface antigen
GB2025256B (en) Gas transfer process using a hollow fibr membrane
SE7602751L (sv) Framstellning av n-acyl-l-metionin
DE3685764D1 (de) Antibiotikum hergestellt von lysobacter sp. sc 14,067.
FI843814A0 (fi) Cyklisk process foer framstaellning av en alkaliloesning av cellulosakarbamat foer utfaellning av karbamaten och foer aotervinning av kemikalierna.
FI891133L (fi) Anordning och verktyg foer tillverkning av alla kaenda gaengtyper (med undantag av saoggaengor) i ett arbetsmoment.
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
DE68924155D1 (de) Verfahren zur herstellung von natürlichem hiv-glykoprotein 160.
FI853618L (fi) Stabilisering av enzymer anvaendbara foer produktion av glukoson och i andra enzymatiska processer.
ES2028968T3 (es) Sistema de gobierno de la produccion.
DE3860692D1 (de) Hohlfaser-oxygenator.
DE3680706D1 (de) Vakuumspinnen von faserbuendeln.
DK702288A (da) Dihydropyranderivater
EP0316189A3 (en) Ir-radiation source and method for producing same
JPS53126262A (en) Molecular beam epitaxial growth apparatus
JPS5430858A (en) Hologram recorder-reproducer
EP0367598A3 (en) Novel process for the production of 4,6-dimethyl-7-hydroxynonan-3-one
EP0248425A3 (en) Emitter with a transistorized push-pull output stage
BG28059A3 (en) Method of stereoselective obtaining of optical active transhexahydrobenzopyranones
IT1215434B (it) Saturazione. stadio amplificatore con uscita di collettore, con controllo della
DE68922778D1 (de) Erzeugung von Fehlernachrichtenanzeige.